Sanofi-Aventis SA, France’s largest drugmaker, got about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme Corp., two people familiar with the situation said.
The loans may be refinanced by bonds after the acquisition is completed, said the people, who declined to be identified because the information is private. JPMorgan Chase & Co., BNP Paribas SA and Societe Generale SA are providing the financing.
Sunday, September 12, 2010
Sanofi-Aventis Said to Get $10 Billion Loans for Genzyme Bid - BusinessWeek